Replies to post #123946 on Biotech Values

[iandy]

Biogen estimated 52,700 patients on Tysabri as of June 2010.
They are estimating 61,500 as of June 2011.

The price hikes have had an effect but that's over 14% more patients on Tysabri YOY.